AB Science delays 2024 financial report, now due May 9, 2025, due to auditor updates.

From GlobeNewswire: 2025-05-01 04:06:00

AB Science SA has announced a delay in the publication of its 2024 annual financial report to allow auditors more time to complete their work. The report will now be released no later than May 9, 2025. The company specializes in protein kinase inhibitors and targets diseases with high unmet medical needs. AB Science’s lead compound, masitinib, is in development for various medical conditions. Investors are cautioned that forward-looking statements are subject to risks and uncertainties. For more information, contact AB Science’s Financial Communication & Media Relations team at [email protected].



Read more at GlobeNewswire: AB Science will publish its 2024 annual financial report on